Document is current
Any future updates will be listed below
-
Authors
Skubitz, Amy P. N.
Boylan, Kristin L. M.
Liu, Limeng
Petersen, Ashley
Gao, Yuqian
Hansen, Joshua R.
Trejo, Jesse B.
Fillmore, Thomas L.
Wang, Yang
Geller, Melissa A.
Argenta, Peter A.
Hoffman, Samantha
Rodland, Karin
Liu, Tao
Piehowski, Paul D.
-
Funding
Funding for this research was provided by:
University of Minnesota Masonic Cancer Center Brainstorm Award
Minnesota Ovarian Cancer Alliance
Cancurables Foundation
Department of Defense Ovarian Cancer Research Program Pilot Award (W81XWH-16-1-0070)
Department of Defense Ovarian Cancer Research Program Teal Award (W81XWH-22-1-0486)
National Institutes of Health National Cancer Institute (5R01CA262153)
University of Minnesota’s NIH Clinical and Translational Science Award (UM1TR004405)
NIH P30 grant for the Biostatistics Core shared resource of the Masonic Cancer Center (CA77598)
National Center for Advancing Translational Sciences of the National Institutes of Health Award (UM1TR004405)
- License Information
-
More Information
Article History
Received: 3 March 2026
Accepted: 30 April 2026
First Online: 17 June 2026
Declarations
:
: “Mock” Pap tests were obtained from women in the clinic or preoperatively under approval from the University of Minnesota Institutional Review Board (Protocol #1112M07362) to mimic the sample collection that would occur in a clinical setting, using a Pap test broom and a SurePath™ vial (BD Biosciences).
: Not applicable.
: The authors declare no competing interests.
